Navigation Links
Gen-Probe Announces Webcasts of Three Upcoming Investor Events

- Third Quarter 2008 Earnings Conference Call on October 30 -

- Presentation at Oppenheimer's 19th Annual Healthcare Conference on

November 4 - - Annual Analyst Day for Institutional Investors and Financial Analysts on

November 7 -

SAN DIEGO, Oct. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will webcast three upcoming investor events.

First, Gen-Probe will release its third quarter 2008 financial results on Thursday, October 30, 2008 at approximately 4:00 pm Eastern Time (ET), followed by a conference call with management at 4:30 pm ET. The conference call will be webcast live and may be accessed on the investors section of the Company's web site at An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 866-505-9257 (US) or 203-369-1881 (international).

Second, the Company will present at Oppenheimer's 19th Annual Healthcare Conference in New York on Tuesday, November 4, 2008 at 12:40 pm ET. The presentation is scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

Third, Gen-Probe will webcast its annual meeting with institutional investors and sell-side analysts in San Diego on Friday, November 7, 2008, at 8 am Pacific Time (11 am ET). The meeting, which will feature presentations on Gen-Probe's current business and future growth strategies, will conclude at approximately 11 am Pacific Time (2 pm ET). Institutional investors and sell-side analysts can RSVP to attend in person by contacting Paula Izidoro at Please note the new date and time. Others may access a live webcast through a link on the investors section of Gen-Probe's website. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended June 30, 2008, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.


Paula Izidoro

Investor Relations


SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
3. Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
4. Gen-Probe to Webcast Presentation at Deutsche Bank Small- and Mid-Cap Growth Conference
5. Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
6. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
7. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
8. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
9. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
10. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
11. RF Technologies(R) Announces Code Alert(R) Integrated Care Management Solution
Post Your Comments:
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: